Form 4: ATAI Life Sciences Chief Medical Officer Sells Shares to Cover Tax Obligations

Kevin James Craig, Chief Medical Officer of ATAI Life Sciences N.V., sold 11,563 common shares on March 21, 2025, at a price of $1.35 to cover tax liabilities related to vesting restricted stock units.

Summary

• On March 21, 2025, Kevin James Craig, the Chief Medical Officer of ATAI Life Sciences N.V., sold 11,563 common shares.
• The shares were sold at a price of $1.35 per share.
• The sale was executed to satisfy the reporting person's tax liability on the vesting of restricted stock units.
• Following the transaction, Craig directly owns 8,437 common shares.

Sentiment

Score: 5

Explanation: The document describes a routine transaction (sale of shares to cover tax obligations) by a company executive, which is neither particularly positive nor negative.

Industry Context

Sales of shares by company executives are a normal part of corporate governance. It is common for executives to sell shares to cover tax obligations when restricted stock units vest.

Stakeholder Impact

• The sale of shares by an executive could have a minor impact on shareholder sentiment, but is unlikely to have a significant impact on other stakeholders.

Key Dates

Keywords

ATAI Life Sciences, Chief Medical Officer, Kevin James Craig, Form 4, Share Sale, Tax Liability, Restricted Stock Units, Beneficial Ownership